Očková, M.; Anunciación-Llunell, A.; Andrada, C.; Esteve-Valverde, E.; Miró-Mur, F.; Alijotas-Reig, J.
IgM Antiphospholipid Antibodies in Antiphospholipid Syndrome: Prevalence, Clinical Associations, and Diagnostic Implications—A Scoping Review. J. Clin. Med. 2025, 14, 7164.
https://doi.org/10.3390/jcm14207164
AMA Style
Očková M, Anunciación-Llunell A, Andrada C, Esteve-Valverde E, Miró-Mur F, Alijotas-Reig J.
IgM Antiphospholipid Antibodies in Antiphospholipid Syndrome: Prevalence, Clinical Associations, and Diagnostic Implications—A Scoping Review. Journal of Clinical Medicine. 2025; 14(20):7164.
https://doi.org/10.3390/jcm14207164
Chicago/Turabian Style
Očková, Monika, Ariadna Anunciación-Llunell, Catalina Andrada, Enrique Esteve-Valverde, Francesc Miró-Mur, and Jaume Alijotas-Reig.
2025. "IgM Antiphospholipid Antibodies in Antiphospholipid Syndrome: Prevalence, Clinical Associations, and Diagnostic Implications—A Scoping Review" Journal of Clinical Medicine 14, no. 20: 7164.
https://doi.org/10.3390/jcm14207164
APA Style
Očková, M., Anunciación-Llunell, A., Andrada, C., Esteve-Valverde, E., Miró-Mur, F., & Alijotas-Reig, J.
(2025). IgM Antiphospholipid Antibodies in Antiphospholipid Syndrome: Prevalence, Clinical Associations, and Diagnostic Implications—A Scoping Review. Journal of Clinical Medicine, 14(20), 7164.
https://doi.org/10.3390/jcm14207164